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Differential Path-length Spectroscopy (DPS) was used to non-invasively determine the optical properties
of oral leukoplakias in vivo. DPS yields information on microvascular parameters such as the mucosal
blood content, the microvascular blood oxygenation and the average micro-vessel diameter as well as
on tissue morphological parameters such as the scattering slope and scattering amplitude. DPS measure-
ments were made on non-dysplastic and dysplastic oral leukoplakias using a novel ﬁber-optic probe, and
were correlated to the histological outcome of biopsies taken from the same location. Our data show bor-
derline signiﬁcant increases in mucosal blood content in dysplastic lesions compared to non-dysplastic
lesions, with no changes in microvascular oxygen saturation and light scattering signatures. These results
suggest that dysplastic and non-dysplastic leukoplakias may be discriminated non-invasively in vivo
through differences in their microvascular properties, if they can be reproducibly quantiﬁed in the pres-
ence of a variable thickness keratin layer that optically shields the mucosal layer.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
Oral cancer is the sixth most common malignancy in the Euro-
pean population and is the ﬁrst in India.1 Worldwide it shows
increasing incidence andmortality rates. Globally, there are around
270,000 new cases annually and 145,000 deaths, of which two-
thirds occur in developing countries.2 The main risk factors for
developing oral cancer are tobacco and alcohol use.3,4 The detec-
tion of small, early-stage oral cancer has been shown to lead to sig-
niﬁcantly reduced mortality and morbidity.5
Early detection of oral cancer and especially its precursors re-
mains the best way to ensure patient survival and quality of life.
Oral cancer is predominantly preceded by white (leukoplakia) or
red (erythroplakia) lesions that are often present for a considerable
period of time prior to malignant transformation and readily acces-
sible for visual inspection. In spite of this visual accessibility, the
percentage of oral cancers diagnosed in the early stages remains
similar to that of the much less accessible colon cancers (36%).6
The main problem in visual screening for oral cancer is that it is ex-
tremely difﬁcult to visually distinguish premalignant (i.e. dysplas-
tic or worse) from benign (i.e. non-dysplastic) leukoplakias. Since
the prevalence of leukoplakias is reported to be as high as 1–5%adiation Oncology, Erasmus
ds. Tel.: +31 10 7032104; fax:
link).
ier OA license.of the general population,7 while the annual malignant transfor-
mation probability of leukoplakias is less than 1%,8 it is very expen-
sive and highly undesirable to take biopsies from all leukoplakias
presented during routine screening. Not only the ﬁnancial side of
such a high false positive rate is a problem for implementing an
oral screening program, but also patients may be reluctant to sub-
mit to an invasive and painful biopsy when their doctor’s conﬁ-
dence as to the nature of the lesion is low. This applies even to
patients who previously had oral cancer and are subjected to visual
inspection several times per year because of their high chances of
developing a second primary cancer; they are often unmotivated to
undergo further biopsies. A non-invasive tool that would help to
reduce the number of unnecessary biopsies would greatly improve
the cost effectiveness as well as patient compliance to screening
programs for high risk patients. Moreover, such a tool might enable
cost effective screening of the general population.
Differential Path-length Spectroscopy (DPS) is a ﬁberoptic tech-
nique that uses white light and has the capability to extract rele-
vant biological information from a very small and superﬁcial
tissue volume.9,10 DPS is particularly suitable for non-invasive
in vivo measurements of microvascular blood content, oxygen sat-
uration and microvascular diameter, which are parameters be-
lieved to be relevant for the prognosis of (pre)malignant
tissue.11–15 We have previously investigated the correlation be-
tween DPS parameters measured in vivo on normal and cancerous
oral mucosa and the histology of the corresponding biopsies.16 In
that study we observed signiﬁcant differences in the scattering
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ties (related to microvascular properties) of normal and cancerous
tissue. As stated previously, however, the diagnostic challenge in
oral cancer screening is to discriminate non-dysplastic from dys-
plastic (or worse) leukoplakias. Therefore, the aim of the present
study was to ﬁnd distinguishing differences in the optical proper-
ties of non-dysplastic and dysplastic oral leukoplakias in vivo.Material and methods
Study population
Eighteen patients (6 males and 12 females, age 63 ± 15 years)
were included. All patients had one or more leukoplakia that re-
quired a biopsy for histological diagnosis. Both the number of biop-
sies as well as their location was determined by the physician
based on their clinical appearance, before the DPS measurements
were performed (i.e. DPS was not used to determine the location
of the biopsies). A total of 27 leukoplakias were measured and
biopsied in these patients. Additionally, 24 measurements were
performed on visually unsuspicious (normal) mucosa; these loca-
tions were not biopsied. All measurements were performed in an
out-patient clinic. All patients were more than 18 years old and
gave informed consent.Experimental setup
The experimental setup used in this study is slightly modiﬁed
from that previously described by Amelink et al.16 Spectra were
measured using a custom-made instrument using a ﬁberoptic
probe containing two bundles of 200 lm ﬁbers each with a total
diameter of 2 mm each (Fig. 1). One of the bundles (the collection
(c)-bundle) is directly connected to a temperature stabilised two-
channel spectrometer (Ocean Optics, Duiven, The Netherlands,
MC-2000-2-TR2). Half of the ﬁbers of the other bundle (the deliv-
ery-and-collection (dc)-bundle) are connected to a light source
(Tungsten Halogen lamp, Ocean Optics, Duiven, The Netherlands,
HL-2000-FHSA), and the other half to the second spectrometer
channel. The assignment of individual ﬁbers within the dc-bundle
to source/spectrograph is randomized, as visualized in the sche-
matic by the shaded or unshaded ﬁbers, such that during measure-
ment, the photons effectively enter and exit the tissue across the
entire 2 mm surface of the dc-bundle. The ﬁber bundles are at
the distal end contained within a 10 cm long stainless steelFigure 1 Fiber-optic bundle used for the DPS-measurements. A tungsten–halogen
lamp is used to deliver light to the oral mucosa through half of the ﬁbers of the
dc-ﬁber (gray), and the remitted light collected in the other half of the dc-ﬁbers and
all the c-ﬁbers is analyzed in a dual channel spectrometer.cylinder of 1 cm diameter. Calibration is performed by dividing col-
lected tissue spectra by spectra recorded with the probe at a ﬁxed
distance (roughly 30 mm) from a diffuse reﬂecting white reﬂec-
tance standard (Labsphere SRS-99). The difference of the dc- and
c-ﬁber collection signals is called the ‘‘differential reﬂectance sig-
nal’’ R(k). We have shown previously that in the range of optical
properties relevant for biological tissue, the differential signal
can be accurately modeled by R(k) = Ccal S(ls(k), p(k,h)) exp(hLi
laðkÞ)).9,10 Here Ccal is a proportionality constant which depends
on the distance between the probe tip and the calibration stan-
dards, S(ls(k), p(k,h)) is a scattering function which depends on
the scattering coefﬁcient ls(k) and the phase function p(k,h, la(k)
is the absorption coefﬁcient, and hLi is the effective differential
path length. It was previously shown that hLi is nearly independent
of the scattering properties of the tissue and depends only on the
diameter of the dc- and c-ﬁbers (dﬁber) and on la(k).17
Examination procedure
The probe was wrapped with a very thin plastic wrap (house-
hold grade), which we veriﬁed to have no effect on the measure-
ments, to avoid contamination of the probe. The probe was then
placed in gentle contact with the tissue under examination. The
duration of reﬂectance spectral acquisition was less than 100 ms.
Three to ﬁve measurements were performed on slightly different
locations within each lesion in order to take into account the tissue
heterogeneity. In each patient it was attempted to measure both on
the leukoplakia and on a contralateral, visually normal mirror-
location. Punch biopsies of all the measured locations were ob-
tained for histology. Biopsy specimens were transported in formal-
dehyde and ﬁxed in parafﬁn. Hematoxylin–eosin stained slides
were evaluated without knowledge of the spectroscopic ﬁndings.
Analysis of spectra
The analysis of our spectra has been described in detail previ-
ously.16–18 In summary, in accordance to Lorentz-Mie and Rayleigh
scattering theory we assumed that the scattering function S(ls(k),
p(k,h)) = a1kb + a2k4, where the power-law scattering slope (b) is
a constant related to the size of the scattering particles.19 Further-
more, the main absorbers in the measured wavelength range
(350–1000 nm) are blood and beta-carotene.20 The complete mod-
el to which the differential path-length spectra are ﬁtted is given
by16–18:
RðkÞ ¼ ða1kb þ a2k4Þ exp½hLilaðkÞ
hLi ¼ 1:08dfiber
1þ ln½1þ 0:71dfiberlaðkÞ
laðkÞ ¼ cbclbca ðkÞ þ CcorBvf ½StO2lHbO2a ðkÞ þ ð1 StO2ÞlHba ðkÞ
ð1Þ
Here cbc is the concentration beta-carotene, lbca ðkÞ is the spe-
ciﬁc absorption coefﬁcient of beta-carotene,21 Ccor is a correction
factor that accounts for the inhomogeneous distribution of blood
in tissue and depends on the vessel diameter Dvessel,22 Bvf is the
blood volume fraction, StO2 is the microvascular blood oxygena-
tion, lHbO2a ðkÞ is the absorption coefﬁcient of fully oxygenated
whole blood,23 and lHba ðkÞ is the absorption coefﬁcient of fully
deoxygenated whole blood.23
Fitting the data to Eq. (1) yields values for StO2, Bvf, Dvessel, cbc,
b, a1 and a2. Conﬁdence intervals on parameter estimates were cal-
culated from the square root of the diagonal of the covariance ma-
trix, as explained in detail previously.24 The scattering amplitude
parameters (a1 and a2) are related to the amplitude of the scatter-
ing signal measured at 800 nm wavelength, where blood absorp-
tion is minimal. These amplitudes depend on the scattering
coefﬁcient ls and scattering phase function p(h) of the tissue, but
Figure 2 Typical DPS measurement of (a) normal oral mucosa and (b) leukoplakia.
The signal dips observed below 600 nm are due to the absorption of light by the
hemoglobin in the microvascular network. The error bars represent the standard
deviations of the 10 pixels used to bin the data.
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standards. Thus the absolute number of these scattering amplitude
parameters is arbitrary, but since all calibrations were performed
at the exact same distance from the spectralon calibration stan-
dard, a comparison between the scattering amplitudes of different
measurements is still valuable.Statistical analysis
The differences in the 7 parameters between the three groups
were evaluated with a Kruskal-Wallis test, and differences be-
tween the non-dysplastic and dysplastic leukoplakias were further
evaluated with a Wilcoxon rank-sum test. These tests were used
due to the small sample size and the non-normal distribution of
the parameters, which makes the student t-test inappropriate. p-
values less than 0.05 were regarded as signiﬁcant.Linear discriminant analysis (LDA)
To evaluate the quality of discrimination between the non-dys-
plastic and dysplastic lesions, linear discriminant analysis was
applied on the subset of spectra measured on leukoplakias. Specif-
ically, a logistic regression model based on the three vascular
parameters was generated to predict the classiﬁcation (dysplastic
or non-dysplastic) of each spectrum measured on a leukoplakia
using a statistical software package (MedCalc). This model was
then used to calculate a receiver operating characteristic (ROC)
curve. When multiple measurements were performed on a single
leukoplakia, the model combines the predictions of the multipleTable 1
Average values and standard deviations (in parentheses) of blood oxygenation (StO2), ves
scattering slope (b), Mie scattering amplitude (a1) and Rayleigh scattering amplitude (a2)
Parameter Normal mucosa (24) Non-dysplastic leukoplakia (15)
StO2 (%) 94 (7) 90 (9)
Bvf (%) 3.6 (2.9) 2.1 (2.1)
Dvessel (lm) 30 (18) 38 (25)
cbc (lM) 1.6 (1.1) 1.0 (1.0)
b () 0.8 (0.3) 1.2 (0.3)
a1 () 1.2 (0.3) 1.1 (0.4)
a2 () 0.01 (0.01) 0.01 (0.02)
Signiﬁcance levels according to the Kruskal-Wallis test (three groups) and Wilcoxon rank
indicated in parentheses.spectra by generating a positive result (i.e. the lesion is classiﬁed
as dysplastic) if at least one of the spectra measured on a leukpla-
kia predicts the presence of dysplasia.Results
Of the 27 leukoplakias included in this data set, 15 lesions were
histologically non-dysplastic (including hyperkeratosis, hyperpla-
sia and lichen planus, often accompanied by inﬂammation) and
12 lesions were histologically dysplastic (7 mild, 1 moderate, 2 se-
vere dysplasias and 2 in situ carcinomas). Figure 2 shows typical
spectra (data points) and ﬁts (solid lines) measured with the
2 mm DPS ﬁber bundle probe on (a) normal oral mucosa and (b)
leukoplakia. Upon ﬁtting the spectra to Eq. (1), the 7 parameters
(StO2, Bvf, Dvessel, cbc, b, a1 and a2) are extracted along with their
conﬁdence intervals.
Three to ﬁve measurements were performed on nearly the same
location within each lesion. Between each of these measurements
the probe was removed from the tissue and then replaced on the
same location with an estimated deviation of less than a few mil-
limeters. This was done to check the reproducibility of the mea-
surements and to take into account the intra-tumor
heterogeneity that possibly already exists on a millimeter scale.
A total of 76 spectra (45 non-dysplastic and 31 dysplastic) were
collected from the 27 leukoplakias. The optical parameters ex-
tracted from all the spectra measured on the same location were
averaged and these averaged values were used to optically charac-
terize each location. Table 1 summarizes the average values and
standard deviations of the optical parameters for the normal, the
non-dysplastic leukoplakias and the dysplastic leukoplakias. Sig-
niﬁcant differences in the parameters are only observed for the
Mie scattering slope (b) and Mie scattering amplitude (a1); these
differences are due to differences in the scattering signatures of
normal mucosa compared to leukoplakias. The blood volume frac-
tion (Bvf) of non-dysplastic leukoplakias is borderline signiﬁcantly
smaller than of normal oral mucosa (p = 0.08). No signiﬁcant differ-
ences are observed between non-dysplastic and dysplastic leuko-
plakias for any of the measured parameters. Within that subset
of data, it is interesting to note that the microvascular oxygen sat-
uration remains high for all measured locations, while the blood
volume fraction of dysplastic lesions is borderline signiﬁcantly
higher than of non-dysplastic lesions (p = 0.08).
Figure 3 shows the result of the linear discriminant analysis
(LDA). The LDA was performed on the microvascular properties
(StO2, Bvf, Dvessel) only, based on the observed lack of statistically
signiﬁcant differences in the scattering properties of non-dysplas-
tic and dysplastic leukoplakias. Based on the combination of these
3 parameters, non-dysplastic and dysplastic leukoplakias can be
discriminated with a sensitivity and speciﬁcity of 91% and 80%,
respectively. The area under the receiver-operating characteristic
(ROC) curve is 0.87, which is ‘‘good’’ but not excellent.sel diameter (Dvessel), blood volume fraction (Bvf), betacarotene concentration (cbc),
measured in normal oral mucosa, non-dysplastic and dysplastic leukoplakias.
Dysplastic leukoplakia (12) p-value (Krus.-Wal.) p-value (Wilcox.)
89 (13) 0.4 0.6
4.1 (3.1) 0.1 0.08
23 (14) 0.3 0.2
1.3 (1.1) 0.3 0.6
1.1 (0.3) 0.001 0.6
0.9 (0.1) 0.01 0.6
0.01 (0.02) 0.3 0.4
-sum test (leukoplakias only) are also reported. The amount of sites in each group is
Figure 3 Receiver operating characteristic (ROC) curve for classiﬁcation of non-
dysplastic and dysplastic leukoplakias.
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In the present study 2 mm diameter ﬁber bundles were used to
non-invasively determine the microvascular and scattering proper-
ties of non-dysplastic and dysplastic oral leukoplakias in vivo using
DPS. This study utilized novel ﬁber-optic bundles with effective ﬁ-
ber diameters of 2 mm to increase the optical interrogation
depth17 compared to our previous study, which utilized 1 mm ﬁ-
bers.16 This was necessary because leukoplakias are characterized
by the presence of (thick) keratin layers that are optically shielding
the mucosa; as a result, in most leukoplakias, a 1 mm DPS probe
does not optically interrogate beyond this keratin layer, hamperingFigure 4 Schematic explanation for observed differences in measured Bvf, (a) for (i) norm
DPS, and (b) in normal oral mucosa using (i) 1 mm vs. (ii) 2 mm DPS. Normal tissue con
layer present in leukoplakias. Microvascular density (MVD) is assumed to be similar foraccurate characterization of their microvascular properties. A ﬁber
bundle with effective diameters of 2 mm was used to increase the
ﬂexibility and reduce the fragility of the probe compared to a probe
that would contain two 2 mm solid core glass rods.
We observed signiﬁcant differences in the Mie scattering slope
(b) and Mie scattering amplitude (a1) between normal mucosa
and leukoplakias (p < 0.05 for both parameters). This is not surpris-
ing since leukoplakias are also visually different fromnormalmuco-
sa; the white appearance of leukoplakias is caused by the presence
of a strongly scattering superﬁcial keratin layer. Interestingly, the
blood volume fraction (Bvf) of non-dysplastic leukoplakias is
borderline signiﬁcantly smaller than of normal oral mucosa
(p = 0.08). This difference is probably related to the observed differ-
ence in scattering properties, as explained schematically in Figure
4a. Most likely the decrease in Bvf in non-dysplastic leukoplakias
is caused by the presence of a keratin layer in leukoplakias, which
effectively increases the distance from the probe-tip to the micro-
vasculature. As a result, the optically interrogated tissue volume
has on average a smaller Bvf for non-dysplastic leukoplakias than
for normalmucosa, even though themucosalmicrovascular density
(MVD) may be the same for both groups. The borderline signiﬁcant
increase in Bvf for dysplastic leukoplakias compared with non-dys-
plastic leukoplakias could be attributed to an increase in MVD,
assuming that the keratin layer thickness is on average the same
in both groups. A similar explanation holds for the observed differ-
ences in measured Bvf of normal oral mucosa in our previous study
using 1 mm diameter ﬁbers (1%)16 compared to the current study
using 2 mm diameter ﬁbers (3.6%). The 2 mm ﬁber bundles probe
approximately twice as deep as the 1 mm ﬁbers,17 increasing the
ratio of mucosal/epithelial sampling volume and thereby increasing
the measured Bvf, even though the MVD has not changed (Figure
4b). Note that the inﬂuence of the keratin layer on the in vivo spec-
tral quantitation of Bvf could potentially be removed by removing
the keratin layer from a leukoplakia using aggressive chemicals
prior to the optical measurements. However, such chemicals cannot
be applied in humans. Furthermore, although these chemicals could
be applied in a proof-of-concept animal study, because the tissue
(and notably the microvasculature) will also react to the chemicalal oral mucosa and (ii) non-dysplastic and (iii) dysplastic leukoplakias using 2 mm
sists of a bloodless epithelial layer on top of the mucosa, with an additional keratin
normal and non-dysplastic mucosa, and increased for dysplastic mucosa.
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resentative microvascular properties.
Within the leukoplakia group, which is of diagnostic relevance,
no signiﬁcant differences are observed between non-dysplastic and
dysplastic lesions for any of the measured parameters. Neverthe-
less, as stated previously, a borderline signiﬁcant difference in
Bvf of non-dysplastic and dysplastic leukoplakias was found
(p = 0.08) which can be attributed to an increased MVD. Such a
trend is in agreement with previously reported increases in MVD
in dysplastic tissues compared to non-dysplastic tissues in the oral
cavity,13,15 as well as with our recent ﬁndings of increased vascu-
larity in dysplastic vs. non-dysplastic esophageal tissues.18 Similar
to the results of our previous studies on the microvasculature of
bronchial mucosa25 and esophageal mucosa18 we did not ﬁnd a de-
crease in oxygen saturation of the microvascular blood of dysplas-
tic tissues in the present study. Our results thus suggest that a
decrease in the oxygen saturation of the microvascular blood oc-
curs only in the more advanced stages of cancer, while increased
microvascularity seems to be an early indicator of the presence
of premalignant disease; an indicator that may be optically mea-
sured in vivo.
LDA using the microvascular properties (StO2, Bvf, Dvessel)
showed that non-dysplastic and dysplastic leukoplakias can be dis-
criminated with a sensitivity and speciﬁcity of 91% and 80%,
respectively. The area under the receiver-operating characteristic
(ROC) curve is 0.87, which is ‘‘good’’ but not excellent. Although
this performance is certainly not sufﬁciently accurate for screening
purposes, the LDA does suggest that non-dysplastic and dysplastic
leukoplakias may be discriminated non-invasively through differ-
ences in their microvascular properties.
The fact that in this study the Bvf of dysplastic leukoplakias, ex-
tracted from the DPS spectra, were only borderline signiﬁcantly
larger than of non-dysplastic leukoplakias, combined with the fact
that the LDA discrimination performance was good but not excel-
lent, is most likely caused by the complex architecture of leuko-
plakias. A major complicating factor in the optical quantitation of
microvascular properties of leukoplakias is the presence of a vari-
able thickness keratin layer. As stated previously, the white appear-
ance of leukoplakias is due to the presence of a strongly scattering
superﬁcial keratin layer; this layer ranges in thickness from several
tens to several hundreds of micrometers and, unfortunately, opti-
cally shields the mucosal layer in which the microvascular changes
take place as cancer starts to develop.11–15 Due to this speciﬁc
morphological challenge presented by the variable thickness
(non-diagnostic and highly scattering) keratin layer in leukoplak-
ias, the optimal interrogation depth will also vary strongly in these
lesions. Other groups have previously demonstrated a similar
inﬂuence of anatomical location on spectral quantitation of micro-
vascular properties.20 The impact of leukoplakia plaque thickness
is very similar to (but probably much more pronounced than)
the impact of anatomy on the optical assessment of microvascular
properties. We therefore believe that the main challenge in opti-
cally assisted oral cancer screening is to develop an optical device
that allows rapid quantitative assessment of microvascular proper-
ties with real-time control over the optically interrogated tissue
depth, which is able to reproducibly quantitate the microvascular
properties in the presence of a variable thickness keratin layer that
optically shields the mucosal layer.
In conclusion, we have characterized the microvascular and
light scattering properties of non-dysplastic and dysplastic oral
leukoplakias, and found preliminary evidence that suggests that
these lesions may be discriminated non-invasively through differ-
ences in their microvascular properties; differences that can only
be reproducibly quantiﬁed in leukoplakias using an optical device
featuring a controllable, variable interrogation depth. We arecurrently developing such a device; future studies will utilize this
device to investigate the biological heterogeneity in keratin layer
thickness as well as in microvascular properties of non-dysplastic
and dysplastic leukoplakias, in order to evaluate the feasibility of
non-invasive optical discrimination of non-dysplastic and dysplas-
tic leukoplakias with high accuracy based on quantiﬁable differ-
ences in their microvascular properties.
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